论文部分内容阅读
预计2006～2011年全球己内酰胺的生产能力将以年均约2.2%的速度增长,到2011年总生产能力将达到约550.0万吨,其中亚洲地区扩能是拉动全球能力增长的主要因素,发展将转向以亚洲为中心。需求量将以年均约2.8%的速度增长,到2011年需求量将达到约460.0万吨。其中北美及西欧地区由于需求增长快于生产能力的增长速度,其装置的开工率将不断提高,而亚洲地区生产能力增幅高于需求,装置的平均开工率将有所下降。
It is estimated that global caprolactam production capacity will grow at an average annual rate of about 2.2% from 2006 to 2011 and total output will reach 5.5 million tons by 2011. Among them, expansion in Asia is a major factor driving global capacity growth. Turn to Asia as the center. Demand will grow at an average annual rate of about 2.8% and demand will reach about 4.6 million tons by 2011. Including North America and Western Europe because of demand growth faster than the growth rate of production capacity, operating capacity of its installations will continue to rise, while the Asian region increased production capacity above demand, the average operating rate of the unit will decline.